Search | TVST | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Automated Development of Deep Learning Models to Diagnose Retinal Disease from Fundus and Optical Coherence Tomography Images

Pearse Andrew Keane; Livia Faes; Siegfried Wagner; Dun Jack Fu; Joseph R Ledsam; Reena Chopra; Christoph Kern; Gabriella Moraes; NIKOLAS PONTIKOS; Martin K Schmid; Lucas M Bachmann; Dawn A Sim; Konstantinos Balaskas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1453. doi:

ARVO Annual Meeting Abstract July 2019

Diagnostic accuracy and interobserver variability of macular disease evaluation using optical coherence tomography

Siegfried Karl Wagner; Reena Chopra; Joseph R Ledsam; Harry Askham; Sam Blackwell; Livia Faes; Konstantinos Balaskas; Trevor Back; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1849. doi:

ARVO Annual Meeting Abstract July 2019

Evaluation of the efficacy of the intravitreal 0.7 mg dexamethasone implant in patients with Diabetic Macular Oedema (DMO) in a Tertiary Referral Center in United Kingdom.

Anastasia Tasiopoulou; Christoph Kern; Dun Jack Fu; Konstantinos Balaskas; Pearse Andrew Keane; Dawn A Sim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2646. doi:

ARVO Annual Meeting Abstract July 2019

Machine Learning for the automated interpretation of Optical Coherence Tomography Angiography for Age-related Macular Degeneration

Konstantinos Balaskas; Abdullah Alfahaid; Hagar Khalid; Panagiotis Sergouniotis; NIKOLAS PONTIKOS; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3095. doi:

ARVO Annual Meeting Abstract July 2019

Fundus autofluorescence in macular telangiectasia type 2

Peter Charbel Issa; Laurenz Pauleikhoff; Tjebo Heeren; Konstantinos Balaskas; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5001. doi:

ARVO Annual Meeting Abstract July 2019

To Compare Patient Satisfaction In Two Different Medical Retina Clinic Settings: Face-to-Face Versus Virtual Clinic

Meriam Islam; Christoph Kern; Karsten Ulrich Kortuem; Konstantinos Balaskas; Pearse Andrew Keane; Dawn A Sim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5438. doi:

ARVO Annual Meeting Abstract July 2019

Anatomical outcomes of patients receiving 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration

Cristina Arpa; Gabriella Moraes; Katrin Fasler; Dun Jack Fu; Siegfried Karl Wagner; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):116. doi:

ARVO Annual Meeting Abstract July 2019

Visual Outcome Following Intravitreal Anti-VEGF Injection In Eyes With Choroidal Neovascular Membrane Secondary to Chronic Central Serous Chorioretinopathy

Filipa Rodrigues; Hagar Khalid; Farid Afshar; Katrin Fasler; Giuseppe Casalino; Magdy Moussa; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5009. doi:

ARVO Annual Meeting Abstract July 2019

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

Faruque Ghanchi; Corinne Fulcher; Sobha Sivaprasad; Konstantinos Balaskas; Richard Peter Gale; Gabriella De Salvo; James S Talks; Andrew Lotery; Ian A Pearce

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3477. doi:

ARVO Annual Meeting Abstract July 2019

REAL LIFE VISUAL ACUITY OUTCOMES FOR PATIENTS TREATED WITH ANTI-VEGF FOR DIABETIC MACULAR OEDEMA IN A TERTIARY REFERRAL CENTER

Josef Huemer; Christoph Kern; Dun Jack Fu; Livia Faes; Siegfried Wagner; Karsten Ulrich Kortuem; Praveen Patel; Konstantinos Balaskas; Dawn A Sim; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3647. doi:

ARVO Annual Meeting Abstract July 2019

Real life structural outcomes in optical coherence tomography for patients treated with anti-VEGF for diabetic macular oedema

Karsten Ulrich Kortuem; Christoph Kern; Dun Jack Fu; Josef Huemer; Livia Faes; Siegfried Wagner; Praveen Patel; Konstantinos Balaskas; Dawn A Sim; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3649. doi:

ARVO Annual Meeting Abstract July 2019

CORRELATION BETWEEN VISUAL ACUITY AND CENTRAL RETINAL THICKNESS FOR PATIENTS TREATED WITH ANTI-VEGF FOR DIABETIC MACULAR OEDEMA

Charles Hennings; Christoph Kern; Dun Jack Fu; Karsten Ulrich Kortuem; Josef Huemer; Livia Faes; Siegfried Karl Wagner; Praveen Patel; Konstantinos Balaskas; Dawn A Sim; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3653. doi:

ARVO Annual Meeting Abstract July 2019

Ultra Wide-Field en face Swept-Source Optical Coherence Tomography Angiography Application in Proliferative Diabetic Retinopathy

Hagar Khalid; Luke Nicholson; Roy Schwartz; Mohamed El-Bradey; Dawn A Sim; Konstantinos Balaskas; Pearse Andrew Keane; Ranjan Rajendram

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3029. doi:

ARVO Annual Meeting Abstract July 2018

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Adnan Tufail; Praveen Patel; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):826. doi:

ARVO Annual Meeting Abstract July 2018

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; NIKOLAS PONTIKOS; Siegfried Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):838. doi:

ARVO Annual Meeting Abstract July 2018

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Daniela Florea; Tatiana Mansour; Traci Clemons; Konstantinos Balaskas; Catherine Egan; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1034. doi:

ARVO Annual Meeting Abstract July 2018

Mortality of patients under anti-VEGF therapy at a large tertiary ophthalmic hospital

GABRIELLA CLAIRE PRESTON; NIKOLAS PONTIKOS; Farid Afshar; Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Adnan Tufail; Konstantinos Balaskas; Praveen Patel; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1469. doi:

ARVO Annual Meeting Abstract July 2018

Five-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1471. doi:

ARVO Annual Meeting Abstract July 2018

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Siegfried K Wagner; Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Thushanthi Ramakrishnan; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):815. doi:

ARVO Annual Meeting Abstract July 2018

Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital

Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Nikolas Pontikos; Farid Afshar; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):816. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Automated Development of Deep Learning Models to Diagnose Retinal Disease from Fundus and Optical Coherence Tomography Images

Diagnostic accuracy and interobserver variability of macular disease evaluation using optical coherence tomography

Evaluation of the efficacy of the intravitreal 0.7 mg dexamethasone implant in patients with Diabetic Macular Oedema (DMO) in a Tertiary Referral Center in United Kingdom.

Machine Learning for the automated interpretation of Optical Coherence Tomography Angiography for Age-related Macular Degeneration

Fundus autofluorescence in macular telangiectasia type 2

To Compare Patient Satisfaction In Two Different Medical Retina Clinic Settings: Face-to-Face Versus Virtual Clinic

Anatomical outcomes of patients receiving 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration

Visual Outcome Following Intravitreal Anti-VEGF Injection In Eyes With Choroidal Neovascular Membrane Secondary to Chronic Central Serous Chorioretinopathy

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

REAL LIFE VISUAL ACUITY OUTCOMES FOR PATIENTS TREATED WITH ANTI-VEGF FOR DIABETIC MACULAR OEDEMA IN A TERTIARY REFERRAL CENTER

Real life structural outcomes in optical coherence tomography for patients treated with anti-VEGF for diabetic macular oedema

CORRELATION BETWEEN VISUAL ACUITY AND CENTRAL RETINAL THICKNESS FOR PATIENTS TREATED WITH ANTI-VEGF FOR DIABETIC MACULAR OEDEMA

Ultra Wide-Field en face Swept-Source Optical Coherence Tomography Angiography Application in Proliferative Diabetic Retinopathy

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Mortality of patients under anti-VEGF therapy at a large tertiary ophthalmic hospital

Five-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital

To View More...

You must be signed into an individual account to use this feature.